Search

This week, Emma Rogan reflects on the best of what makes this time of the year enjoyable. Warning, it includes many cups of tea!

Ocrelizumab is a new medication which has recently been shown in three, large phase-three clinical trials to have beneficial effects in both relapsing-remitting and primary progressive MS. When available, Ocrelizumab will be a welcome addition to the number of drugs currently licensed for relapsing-remitting MS and may also be beneficial to people with primary progressive MS.

MS Ireland funds new mindfulness research project at NUI Galway

Happy New Year from the MS & Me Blog Team. Here’s what 2017 looks like from here... 

MS Ireland is planning to make a submission to the HSE regarding Sativex. If you have been affected by the lack of availability of Sativex, please take a few minutes to complete this short survey, which will help us to develop a strong submission.

Breathing Space

This week Declan Groeger shares his MS journey.

Research Highlights of 2016

Irish actress Aoibhinn McGinnity, Sara-Jane Tracy and her brother James Tracy, Irish rugby player launch campaign

We are currently recruiting for Move Smart MS Move Smart MS offers specialised, online, exercise programmes for people with MS. We have learned that by moving our physiotherapy and exercise programmes online, the barriers of transport, travel time and accessibility are removed.

Our feedback has been overwhelmingly positive. By recruiting nationally, rather than locally, we can bring together groups of people at a similar stage of their MS journey and deliver symptom specific programmes. Move Smart MS is funded by the Innovate Together Fund from Rethink Ireland. You can learn more about the programme and how to register here.

Pamela O'Donnell took part in the programme last year and describes her experience below.